These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11796015)

  • 21. Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3.
    Jia LT; Zhang LH; Yu CJ; Zhao J; Xu YM; Gui JH; Jin M; Ji ZL; Wen WH; Wang CJ; Chen SY; Yang AG
    Cancer Res; 2003 Jun; 63(12):3257-62. PubMed ID: 12810656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of direct translocation across endosomes on the cytotoxicity of the recombinant protein e23sFv-Fdt-casp6 to HER2 positive gastric cancer cells.
    Ren JL; Meng YL; Hu B; Jia LT; Zhang R; Xu YM; Xie QS; Zhang YQ; Jin BQ; Chen SY; Wang T; Yang AG
    Biomaterials; 2011 Oct; 32(30):7641-50. PubMed ID: 21767874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer.
    Yano T; Doi T; Ohtsu A; Boku N; Hashizume K; Nakanishi M; Ochiai A
    Oncol Rep; 2006 Jan; 15(1):65-71. PubMed ID: 16328035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.
    Tolmachev V; Orlova A; Pehrson R; Galli J; Baastrup B; Andersson K; Sandström M; Rosik D; Carlsson J; Lundqvist H; Wennborg A; Nilsson FY
    Cancer Res; 2007 Mar; 67(6):2773-82. PubMed ID: 17363599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stable RNA interference of ErbB-2 gene synergistic with epirubicin suppresses breast cancer growth in vitro and in vivo.
    Hu X; Su F; Qin L; Jia W; Gong C; Yu F; Guo J; Song E
    Biochem Biophys Res Commun; 2006 Aug; 346(3):778-85. PubMed ID: 16781665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer.
    Nakamura K; Yashiro M; Matsuoka T; Tendo M; Shimizu T; Miwa A; Hirakawa K
    Gastroenterology; 2006 Nov; 131(5):1530-41. PubMed ID: 17101326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo.
    Nagasawa J; Mizokami A; Koshida K; Yoshida S; Naito K; Namiki M
    Int J Urol; 2006 May; 13(5):587-92. PubMed ID: 16771730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of recombinant immunotoxins against LeY antigen expressing tumor cells: influence of affinity, size, and stability.
    Bera TK; Pastan I
    Bioconjug Chem; 1998; 9(6):736-43. PubMed ID: 9815167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chimeric T cell receptor N29gamma redirect T lymphocytes response specific to p185HER2 in A murine model of metastatic breast cancer].
    Li SP; Urban FA; Macgregor JN; Hughes DP; McDonagh KT
    Ai Zheng; 2004 Nov; 23(11 Suppl):1370-5. PubMed ID: 15566639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bivalent disulfide-stabilized fragment variable immunotoxin directed against mesotheliomas and ovarian cancer.
    Bera TK; Williams-Gould J; Beers R; Chowdhury P; Pastan I
    Mol Cancer Ther; 2001 Dec; 1(2):79-84. PubMed ID: 12467225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of ligand-mediated HER2 activation in androgen-independent prostate cancer.
    Mendoza N; Phillips GL; Silva J; Schwall R; Wickramasinghe D
    Cancer Res; 2002 Oct; 62(19):5485-8. PubMed ID: 12359757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signaling.
    Wong TW; Lee FY; Yu C; Luo FR; Oppenheimer S; Zhang H; Smykla RA; Mastalerz H; Fink BE; Hunt JT; Gavai AV; Vite GD
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6186-93. PubMed ID: 17062696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo.
    Thorpe PE; Wallace PM; Knowles PP; Relf MG; Brown AN; Watson GJ; Knyba RE; Wawrzynczak EJ; Blakey DC
    Cancer Res; 1987 Nov; 47(22):5924-31. PubMed ID: 3499221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. chFRP5-ZZ-PE38, a large IgG-toxin immunoconjugate outperforms the corresponding smaller FRP5(Fv)-ETA immunotoxin in eradicating ErbB2-expressing tumor xenografts.
    Mazor Y; Noy R; Wels WS; Benhar I
    Cancer Lett; 2007 Nov; 257(1):124-35. PubMed ID: 17698286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of disulfide-stabilized Fv-immunotoxins B1(dsFv)-PE38 and B3(dsFv)-PE38 by continuous infusion increases their efficacy in curing large tumor xenografts in nude mice.
    Benhar I; Reiter Y; Pai LH; Pastan I
    Int J Cancer; 1995 Jul; 62(3):351-5. PubMed ID: 7628878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. rG17PE38, a novel immunotoxin target to gastric cancer with overexpressed CCK-2R.
    Song J; Ren H; Li Y; Xu J; Kong H; Tong W; Zhou Y; Gao S; Liu Y; Hui Q; Peng Q; Lu S; Liu Z
    J Drug Target; 2013 May; 21(4):375-82. PubMed ID: 23311704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
    Griffin TW; Pagnini PG; Houston LL
    J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of anti-erbB-2 recombinant toxin OLX-209 on lung cancer cell lines in the absence of erbB-2 gene amplification.
    Kasprzyk PG; Sullivan TL; Hunt JD; Gubish CT; Scoppa CA; Oelkuct M; Bird R; Fischer PH; Siegfried JM; King CR
    Clin Cancer Res; 1996 Jan; 2(1):75-80. PubMed ID: 9816093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by antitransferrin recombinant immunotoxin.
    Shinohara H; Fan D; Ozawa S; Yano S; Van Arsdell M; Viner JL; Beers R; Pastan I; Fidler IJ
    Int J Oncol; 2000 Oct; 17(4):643-51. PubMed ID: 10995873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of the cytotoxic effect of anti-carcinoembryonic antigen immunotoxins by adenovirus and carboxylic ionophores.
    Griffin TW; Childs LR; FitzGerald DJ; Levin LV
    J Natl Cancer Inst; 1987 Oct; 79(4):679-85. PubMed ID: 3498854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.